🟢 ProKidney is trading 7.39% up today; catalyst remains unclear

ProKidney is trading 7.39% up at $1.52, with no clearly identified company-specific catalyst for the August 21, 2026 move.

• Director Brian JG Pereira sold 757,164 shares for approximately $1,067,773 across August 18–20.
• The transaction does not clearly explain the current gain.
• Biotech sector weakness also does not support the rally, leaving the immediate catalyst uncertain.